Other Clinical Trial - Blood-aqueous Barrier Integrity in Eyes Undergoing

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01950741` - Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy	Phase 4
Recruiting	`NCT01608113` - Long-term Follow-up of Subfoveal Neovascular AMD	N/A
Completed	`NCT01404845` - Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation	N/A
Completed	`NCT01213082` - ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)	Phase 1/Phase 2
Active, not recruiting	`NCT01961414` - Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910	Phase 4
Completed	`NCT01810042` - Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab	Phase 4
Completed	`NCT01304693` - ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients	Phase 1/Phase 2
Completed	`NCT04640272` - A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration	Phase 2
Active, not recruiting	`NCT02976194` - Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy	Phase 4
Completed	`NCT01500915` - FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration	Phase 4
Enrolling by invitation	`NCT05539235` - Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD	Phase 2/Phase 3
Completed	`NCT02355028` - LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration	Phase 2
Unknown status	`NCT02089503` - Monocentric Retrospective Observational Study on Patients With Macular Degeneration	N/A
Completed	`NCT01796964` - Efficacy and Safety Study of ESBA1008 Versus EYLEA®	Phase 2
Completed	`NCT01127360` - LUCAS (Lucentis Compared to Avastin Study)	Phase 4
Terminated	`NCT02348359` - X-82 to Treat Age-related Macular Degeneration	Phase 2
Recruiting	`NCT02328209` - Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration	N/A
Completed	`NCT01849692` - ESBA1008 Microvolume Study	Phase 2
Completed	`NCT01157065` - Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration	Phase 2
Completed	`NCT04138420` - Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab

NCT number	NCT03744806
Study type	Observational
Source	Medical University of Lublin
Contact
Status	Completed
Phase
Start date	January 2015
Completion date	August 2018

Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms